Reviewed by PillSeek Editorial Team · Last verified
Pill Identification
This is a White Capsule pill with imprint U;50, identified as Ubrelvy 50 mg manufactured by AbbVie Inc.. It is supplied as Tablet and distributed under NDC 0023-6498-10.
⚠️ What to verify before taking this medication
- Verify the imprint, color, and shape match exactly — even a single different character can mean a different drug.
- Check the expiration date on the original packaging.
- Look for signs of tampering, discoloration, or unusual odor.
- Confirm with your pharmacist or prescriber before taking any medication you are unsure about.
- Never take medication prescribed to someone else.
This is patient-safety guidance, not medical advice. Read full medical disclaimer.
Basic Information
- Imprint
- U;50
- Color
- White
- Shape
- Capsule
- Size
- 15 mm
Drug Information
- Strength
- 50 mg
- Dosage Form
- Tablet
- Route
- Oral
- RxCUI
- 2268228
- DEA Schedule
- Schedule N/a
Pharmaceutical Classification
- Pharmacologic Class
- Calcitonin gene-related peptide (cgrp) inhibitors
Related Medications
Other drugs in the same class: Calcitonin gene-related peptide (CGRP) inhibitors
Ingredients
- Active Ingredients
- Ubrogepant
- Inactive Ingredients
- Colloidal silicon dioxide, croscarmellose sodium, mannitol, microcrystalline cellulose, polyvinylpyrrolidone vinyl acetate copolymer, sodium chloride, sodium stearyl fumarate, and vitamin e polyethylene glycol succinate.
Additional Information
- Manufacturer
- AbbVie Inc.
- Status (Rx/OTC)
- Rx
- NDC Code
- 0023-6498-10
Frequently Asked Questions
Data Sources
- FDA NDC Directory — Search DailyMed for NDC 0023-6498-10
- RxNorm — View in RxNav (RxCUI: 2268228)
Data last verified:
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.